TAM-derived IL-6 induces tumorigenic and invasive effects and promotes breast, colorectal, and hepatocellular cancer or gastric tumor chemoresistance through the STAT3 signaling pathway [29,33,34,35]. Here, IL6 is linked to hepatocellular carcinoma.